AIM-HI Women's Venture Competition
The AIM-HI Women’s Venture Competition, in its third year, provides early-stage funding, coaching, and networking opportunities to women-led oncology startups to address unmet medical needs. Cash prizes will be awarded to the top three finalists. The winning company will receive up to $1 million in equity investment from AIM-HI and co-investors, subject to due diligence and negotiation. The funding is intended for the startups to generate data for proof of concept and proof of value, on the path to clinical trials and, eventually, to new effective therapeutics and diagnostics that could save patients’ lives.
Please click here to learn more about the Women’s Venture Competition.
The 2023 AIM-HI Women’s Venture Competition is Open for Applications!
Have you heard? The application for the 2023 AIM-HI Women's Venture Competition is now open to women-led, early-stage oncology companies…
2022 AIM-HI Women’s Venture Competition Announced 6 Semi-Finalists!
The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the 2022 AIM-HI Women’s Venture Competition! These innovative oncology start-ups…
Applications Open for the 2022 AIM-HI Women’s Venture Competition!
We have great news to share! The 2022 AIM-HI Women’s Venture Competition is Now Open for Applications! This unique funding…